Invention Grant
US09574001B2 Humanized single-chain antibody against beta 3 integrin for the treatment and prevention of metastasis
有权
针对β3整联蛋白的人源化单链抗体用于治疗和预防转移
- Patent Title: Humanized single-chain antibody against beta 3 integrin for the treatment and prevention of metastasis
- Patent Title (中): 针对β3整联蛋白的人源化单链抗体用于治疗和预防转移
-
Application No.: US13958145Application Date: 2013-08-02
-
Publication No.: US09574001B2Publication Date: 2017-02-21
- Inventor: Thomas M. Wisniewski , Wei Zhang , Suying Dang
- Applicant: Thomas M. Wisniewski , Wei Zhang , Suying Dang
- Applicant Address: US NY New York
- Assignee: New York University
- Current Assignee: New York University
- Current Assignee Address: US NY New York
- Agency: LeClairRyan, a Professional Corporation
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K39/00
Abstract:
The present invention relates to methods inhibiting tumor metastasis and treating cancer in a subject that involve administering to the subject an antibody which recognizes GPIIIa49-66, under conditions effective to inhibit tumor metastasis and/or treat cancer in the subject.
Public/Granted literature
- US20140037629A1 HUMANIZED SINGLE-CHAIN ANTIBODY AGAINST BETA 3 INTEGRIN FOR THE TREATMENT AND PREVENTION OF METASTASIS Public/Granted day:2014-02-06
Information query
